The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity
GAS5 appears to modulate NF-κB activity in a complex manner, influencing both basal and GC-induced signaling. The interaction between GAS5, GCs, and NF-κB is multi-faceted, and further research is needed to fully elucidate the underlying mechanisms. These findings suggest that GAS5 could be a potential target for personalized therapy, particularly in pediatric patients with inflammatory conditions.
Authors
- Biljana Stanković (ORCID: https://orcid.org/0000-0002-7571-277X)
- Debora Curci (ORCID: https://orcid.org/0000-0002-3273-9489)
- Letizia Pugnetti (ORCID: https://orcid.org/0000-0002-9030-4803)
- Sonja Pavlović (ORCID: https://orcid.org/0000-0002-2915-1641)
- Gabriele Stocco (ORCID: https://orcid.org/0000-0003-0964-5879)
- Branka Zukić (ORCID: https://orcid.org/0000-0002-3518-6330)
- Vladimir Gašić (ORCID: https://orcid.org/0000-0001-9589-5502)
- Nikola Kotur
- Maurizio Romano (ORCID: https://orcid.org/0000-0002-4820-2897)
- Marianna Lucafò (ORCID: https://orcid.org/0000-0003-1355-3782)
- Giuliana Decorti (ORCID: https://orcid.org/0000-0002-9714-6246)
Institutions
- University of Trieste (IT)
- IRCCS Materno Infantile Burlo Garofolo (IT)
- University of Belgrade (RS)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.3389/fphar.2024.1448136
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.86
Funders
- Ministero della Salute